MSJ
@msj_research
We are committed to provide our readers with leading information on all aspects of MS, NMO and related autoimmune diseases of the central nervous system.
ID: 764125362422972416
http://journals.sagepub.com/home/msj 12-08-2016 15:44:17
3,3K Tweet
4,4K Followers
195 Following
‘Quality of life is impaired in #MOGAD!’ Congrats to Yana Said, Elias Sotirchos & team from Johns Hopkins Medicine as well as Jenny Khazen, Julia L & Jen G from The MOG Project who are co-authors in this article published in MSJ. Read here: journals.sagepub.com/doi/10.1177/20… Results
OCT measures (RNFL and GCIPL) need re-baseline after 6–12 months to improves differentiation of disease-modifying treatments' effects in #MultipleSclerosis, by avoiding carry-over confounding from previous disease activity. Study from MedUni Wien ▶️ journals.sagepub.com/doi/full/10.11…
Word-finding difficulty in #MultipleSclerosis is associated with worse phonemic processing, and with disease-related cortical changes within the posterior superior temporal/supramarginal region. Study from Mount Sinai Health System Mount Sinai Neurology ▶️ journals.sagepub.com/doi/abs/10.117…
📢August issue is now available ▶️ journals.sagepub.com/toc/MSJ/current ...and the cover goes to The Florey Melbourne School of Population and Global Health University of Tasmania Menzies Institute for Medical Research University of Melbourne with increasing prevalence of #MultipleSclerosis in Australia from 2010 to 2021 ▶️ journals.sagepub.com/doi/abs/10.117…
Letter from Adil Harroud The Neuro McGill University Cambridge University UC San Francisco: The International #MultipleSclerosis Genetics Consortium is committed to collaborative genetic research (and further understand the effects of rs10191329 in #MultipleSclerosis). 🔽 journals.sagepub.com/doi/full/10.11…
And response from Assoc Professor Vilija Jokubaitis Monash STM Neuroscience Monash University MSBase Registry: We need to consider the use of more modern and sophisticated approaches, including machine learning methodology, to be replicated on different datasets. 🔽 journals.sagepub.com/doi/full/10.11…
Ocrelizumab in people with #MultipleSclerosis with persistence of disease activity after alemtuzumab seemed to be safe and effective, though IgM hypogammaglobulinemia was common. A multi-center 🇮🇹 study from caterina lapucci Matilde Inglese Università di Genova ▶️ journals.sagepub.com/doi/abs/10.117…
An automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for #MultipleSclerosis. Re-analysis of BRAVO clinical trial from Noemi Montobbio Università di Genova ▶️ journals.sagepub.com/doi/abs/10.117…
So pleased to announce Prof Kerstin Hellwig is the 2024 winner of the Rachel Horne Prize for Women's Research in MS! Dr Hellwig, neurologist/clinician at Ruhr-Universität Bochum in Germany, is being honoured for her pioneering work into MS & family planning. Prize to be given at ECTRIMS
The era of harmonised disability outcomes in #MultipleSclerosis. Link to the package msprog for R ▶️ github.com/noemimontobbio… Link to web-based graphical interface▶️ msprog.shinyapps.io/MSprog/ And finally link to commentary from University of Melbourne The Royal Melbourne Hospital ▶️ journals.sagepub.com/doi/full/10.11…
People with MOG-Ab associated disease #MOGAD exhibit impairments in multiple domains of quality of life, including anxiety, stigma, cognitive function and social interactions. Study from Yana Said Elias Sotirchos Johns Hopkins Medicine Jenny Khazen The MOG Project ▶️ journals.sagepub.com/doi/full/10.11…
MSJ Yana Said Elias Sotirchos Johns Hopkins Medicine Jenny Khazen Thank you MSJ for supporting our work! 😊
The positive predictive value of MOG-IgG testing based on 2023 criteria for #MOGAD was 78.3% overall and 90.1% for high titer (higher in children than adults and lower in patients without core clinical features). Study from UT Southwestern Medical Center ▶️ journals.sagepub.com/doi/10.1177/20…
